A. Joslyn

发表

Ondansetron is effective in decreasing postoperative nausea and vomiting

C. Rosow, M. Dershwitz, P. Di Biase, 1992, Clinical pharmacology and therapeutics.

Prophylactic intravenous ondansetron in female outpatients undergoing gynaecological surgery: a multicentre dose-comparison study.

C. Mcleskey, J. Angel, R. Mckenzie, 1992, European journal of anaesthesiology. Supplement.

Comparison of Ondansetron Versus Placebo to Prevent Postoperative Nausea and Vomiting in Women Undergoing Ambulatory Gynecologic Surgery

C. Mcleskey, J. Angel, R. Mckenzie, 1993, Anesthesiology.

A randomized, double-blind pilot study examining the use of intravenous ondansetron in the prevention of postoperative nausea and vomiting in female inpatients.

C. Rosow, R. Mckenzie, B. Tantisira, 1993, Journal of clinical anesthesia.

Ondansetron prevents postoperative emesis in male outpatients

P. Scuderi, F. Cox, A. Joslyn, 1996 .

Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group.

P. Scuderi, F. Cox, A. Joslyn, 1996, Journal of clinical anesthesia.

Calcium Channels in Smooth Muscle

A. M. Triggle, D. Triggle, A. Joslyn, 1989 .

Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activators related to Bay K 8644 in smooth muscle, cardiac muscle and neuronal preparations

D. Langs, D. Triggle, A. Joslyn, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Chemical Pharmacology of Ca2+ Channel Ligands

D. Triggle, D. Rampe, A. Skattebøl, 1986 .

Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers.

D. Triggle, D. Koppel, L. Herbette, 1987, Biophysical journal.

A double-blind, placebo-controlled pilot study examining the effectiveness of intravenous ondansetron in the prevention of postoperative nausea and emesis.

B. Wetchler, A. Joslyn, D. Duncalf, 1993, Journal of clinical anesthesia.

Dimeric 1,4-dihydropyridines as calcium channel antagonists.

D. Triggle, A. Joslyn, E. Luchowski, 1988, Journal of medicinal chemistry.

Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) series.

D J Triggle, R Fossheim, A Joslyn, 1988, Journal of medicinal chemistry.

Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group.

N. Leidy, D. Patterson, R. McCallum, 1998, Clinical therapeutics.

Change in Intracellular Cyclic Nucleotide Content Accompanies Relaxation of the Isolated Canine Internal Anal Sphincter

A. Joslyn, M. Barnette, M. Grous, 1991 .

Calcium channels in smooth muscle. Properties and regulation.

A M Triggle, D J Triggle, A Joslyn, 1989, Annals of the New York Academy of Sciences.

Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions

A. Joslyn, 1994, Anaesthesia.

Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double‐blind studies

L. van Nueten, A. Joslyn, G. Tytgat, 2002, Alimentary pharmacology & therapeutics.

A33 RANDOMIZED, DOUBLE‐BLIND COMPARISON OF ONDANSETRON AND PLACEBO IN THE TREATMENT OF POSTOPERATIVE NAUSEA AND VOMITING

H. Zaren, M. Afshar, K. Simansky, 1990 .

A739 ONDANSETRON, A SELECTIVE SEROTONIN TYPE 3 (5-HT3) ANTAGONIST, REDUCES NAUSEA AND VOMITING IN FEMALES FOLLOWING MAJOR GYNECOLOGIC SURGERY

R. Mckenzie, A. Joslyn, T. Rudy, 1990 .

Cyclic Nucleotides Increase During Neuronally Induced Relaxation of Sphincteric and Nonsphincteric Gastrointestinal Smooth Muscle

F. Barone, C. D. Manning, A. Joslyn, 1990 .

The Effects of the Menstrual Cycle on the Incidence of Emesis and Efficacy of Ondansetron

A. Joslyn, I. Gratz, M. Afshar, 1996, Anesthesia and analgesia.

The clinical development of ondansetron for use in the prevention and treatment of postoperative nausea and vomiting.

C. Haigh, A. Joslyn, L. A. Kaplan, 1992, European Journal of Anaesthesiology - Supplement.

Severe oral mucositis (SOM) mitigation by genetically modified lactococcus lactis bacteria (LLB) producing human trefoil factor 1 (hTFF1; AG013) in patients being treated with concomitant chemoradiation (CRT) for oral and oropharyngeal cancers (OCOPC)

Yuhchyau Chen, S. Sonis, S. Thatcher, 2019, Annals of Oncology.